| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 732111 | 04296002IP5 | CYMBALTA 60 MG CAPSULAS DURAS GASTRORRESISTENTES | CYMBALTA 60 MG CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 60 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04296002IP5/04296002IP5_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04296002IP5/04296002IP5_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20183 | ABACUS MEDICINE A/S | 2021-11-02 | 1 | 1 | 1 | 2021-11-03 | 2021-11-02 | 1 | 2023-08-28 | View Edit Delete | ||||||||||||
| 988261 | 58266 | CYMEVENE 500 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | CYMEVENE 500 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION , 5 viales | 500 mg | 45 | 5 | 34 | 5 viales | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58266/58266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58266/58266_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 1989-04-01 | 1 | 1 | 1 | 1989-04-01 | 1989-04-01 | 0 | 2011-10-19 | View Edit Delete | ||||||||||||
| 705110 | 114957001 | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114957001/114957001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114957001/114957001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71735 | LILLY S.A. | 2015-02-16 | 1 | 1 | 1 | 2015-02-16 | 2015-02-16 | 1 | 2015-10-09 | View Edit Delete | ||||||||||||
| 705113 | 114957003 | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114957003/114957003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114957003/114957003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71735 | LILLY S.A. | 2015-02-16 | 1 | 1 | 1 | 2015-02-16 | 2015-02-16 | 1 | 2015-10-09 | View Edit Delete | ||||||||||||
| 727713 | 114957003IP | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114957003IP/114957003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114957003IP/114957003IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 20183 | ABACUS MEDICINE A/S | 2020-01-14 | 1 | 1 | 1 | 2020-01-15 | 2020-01-14 | 1 | 2020-05-15 | View Edit Delete | ||||||||||||
| 731022 | 114957001IP | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114957001IP/114957001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114957001IP/114957001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 20183 | ABACUS MEDICINE A/S | 2021-05-18 | 1 | 1 | 1 | 2021-05-19 | 2021-05-18 | 1 | 2021-08-11 | View Edit Delete | ||||||||||||
| 658697 | 06379001 | CYSTADANE 1 g POLVO ORAL | CYSTADANE 1 g POLVO ORAL , 1 frasco de 180 g + 3 cucharas graduadas | 1 g/g | 6 | 180 | 21 | 1 frasco de 180 g + 3 cucharas graduadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06379001/06379001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06379001/06379001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2007-04-25 | 1 | 1 | 1 | 2007-04-25 | 2007-04-25 | 0 | 2011-05-10 | View Edit Delete | ||||||||||||
| 661454 | 97039003 | CYSTAGON 150 mg CAPSULAS DURAS | CYSTAGON 150 mg CAPSULAS DURAS, 100 cápsulas | 150 mg | 6 | 100 | 43 | 100 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97039003/97039003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97039003/97039003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2000-05-30 | 1 | 1 | 1 | 2000-05-30 | 2000-05-30 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 661470 | 97039001 | CYSTAGON 50 mg CAPSULAS DURAS | CYSTAGON 50 mg CAPSULAS DURAS, 100 cápsulas | 50 mg | 6 | 100 | 43 | 100 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97039001/97039001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97039001/97039001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2000-05-30 | 1 | 1 | 1 | 2000-05-30 | 2000-05-30 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 716784 | 82236 | CYSTUROL COMPRIMIDOS RECUBIERTOS CON PELICULA | CYSTUROL COMPRIMIDOS RECUBIERTOS CON PELICULA, 20 comprimidos | 108-120 mg/46,25 mg/40 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82236/82236_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82236/82236_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 41087 | LABORATORIOS DEITERS S.L. | 2017-07-07 | 1 | 1 | 1 | 2017-07-08 | 2017-07-07 | 1 | 2025-04-08 | View Edit Delete | ||||||||||||
| 990317 | 58403 | CYTOTEC 200 MICROGRAMOS COMPRIMIDOS | CYTOTEC 200 MICROGRAMOS COMPRIMIDOS , 40 comprimidos | 200 microgramos | 5 | 40 | 10 | 40 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58403/58403_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58403/58403_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 1989-10-01 | 1 | 1 | 1 | 1989-10-01 | 1989-10-01 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 768510 | 90566 | DABIGATRAN ETEXILATO ALTER GENERICOS 110 MG CAPSULAS DURAS EFG | DABIGATRAN ETEXILATO ALTER GENERICOS 110 MG CAPSULAS DURAS EFG, 60 cápsulas | 110 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90566/90566_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90566/90566_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2025-09-24 | 1 | 1 | 1 | 2025-09-24 | 2025-09-24 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 768506 | 90564 | DABIGATRAN ETEXILATO ALTER GENERICOS 150 MG CAPSULAS DURAS EFG | DABIGATRAN ETEXILATO ALTER GENERICOS 150 MG CAPSULAS DURAS EFG, 60 cápsulas | 150 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90564/90564_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90564/90564_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2025-09-24 | 1 | 1 | 1 | 2025-09-24 | 2025-09-24 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 762332 | 88692 | DABIGATRAN ETEXILATO CINFA 110 MG CAPSULAS DURAS EFG | DABIGATRAN ETEXILATO CINFA 110 MG CAPSULAS DURAS EFG, 10 cápsulas | 110 mg | 5 | 10 | 43 | 10 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88692/88692_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88692/88692_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2023-03-01 | 1 | 1 | 1 | 2023-03-02 | 2023-03-01 | 1 | 2024-02-13 | View Edit Delete | ||||||||||||
| 762333 | 88692 | DABIGATRAN ETEXILATO CINFA 110 MG CAPSULAS DURAS EFG | DABIGATRAN ETEXILATO CINFA 110 MG CAPSULAS DURAS EFG, 30 cápsulas | 110 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88692/88692_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88692/88692_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2023-03-01 | 1 | 1 | 1 | 2023-03-02 | 2023-03-01 | 1 | 2024-02-13 | View Edit Delete | ||||||||||||
| 762334 | 88692 | DABIGATRAN ETEXILATO CINFA 110 MG CAPSULAS DURAS EFG | DABIGATRAN ETEXILATO CINFA 110 MG CAPSULAS DURAS EFG, 60 cápsulas | 110 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88692/88692_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88692/88692_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2023-03-01 | 1 | 1 | 1 | 2023-03-02 | 2023-03-01 | 1 | 2024-02-13 | View Edit Delete | ||||||||||||
| 762331 | 88691 | DABIGATRAN ETEXILATO CINFA 150 MG CAPSULAS DURAS EFG | DABIGATRAN ETEXILATO CINFA 150 MG CAPSULAS DURAS EFG, 60 cápsulas | 150 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88691/88691_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88691/88691_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2023-03-01 | 1 | 1 | 1 | 2023-03-02 | 2023-03-01 | 1 | 2024-02-13 | View Edit Delete | ||||||||||||
| 766017 | 89894 | DABIGATRAN ETEXILATO COMBIX 110 MG CAPSULAS DURAS EFG | DABIGATRAN ETEXILATO COMBIX 110 MG CAPSULAS DURAS EFG, 30 cápsulas | 110 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89894/89894_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89894/89894_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2024-10-21 | 1 | 1 | 1 | 2024-10-22 | 2024-10-21 | 1 | 2025-01-13 | View Edit Delete | ||||||||||||
| 766018 | 89894 | DABIGATRAN ETEXILATO COMBIX 110 MG CAPSULAS DURAS EFG | DABIGATRAN ETEXILATO COMBIX 110 MG CAPSULAS DURAS EFG, 60 cápsulas | 110 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89894/89894_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89894/89894_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2024-10-21 | 1 | 1 | 1 | 2024-10-22 | 2024-10-21 | 1 | 2025-01-13 | View Edit Delete | ||||||||||||
| 766035 | 89898 | DABIGATRAN ETEXILATO COMBIX 150 MG CAPSULAS DURAS EFG | DABIGATRAN ETEXILATO COMBIX 150 MG CAPSULAS DURAS EFG, 60 cápsulas | 150 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89898/89898_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89898/89898_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2024-10-24 | 1 | 1 | 1 | 2024-10-25 | 2024-10-24 | 1 | 2025-01-13 | View Edit Delete |
Page 238 of 1036, showing 20 records out of 20704 total, starting on record 4741, ending on 4760